Related Experiment Video
Updated: May 14, 2026

Mitochondrial Preparation from Microglia for Glycan Analysis
Published on: May 30, 2025
Inflammatory response of microglial BV-2 cells includes a glycolytic shift and is modulated by mitochondrial
Ludmila A Voloboueva1, John F Emery, Xiaoyun Sun
1Department of Anesthesia, Stanford University School of Medicine, 300 Pasteur Drive, Grant Building S272, Stanford, CA 94305, United States. ludmilav@stanford.edu
Abstract:
Recent studies suggest a link between mitochondria and proinflammatory cytokine generation. We previously demonstrated that overexpression of mitochondrial chaperone glucose-regulated protein75 (Grp75/mortalin) protects mitochondria. In this study we investigated the modulation of the lipopolisaccharide (LPS)-induced inflammatory response of microglial BV-2 cells by Grp75. We demonstrate that LPS-induced activation promotes significant metabolic changes suppressing mitochondrial function and increasing glycolysis. Overexpression of Grp75 attenuates the LPS-induced oxidative and metabolic responses, and suppresses proinflammatory activation, which depends on both NF-κB activation and lactate. Thus overexpression of Grp75 provides a novel strategy to modulate proinflammatory cytokine production of relevance to inflammation-associated pathologies.
Insights
Overexpression of glucose-regulated protein75 (Grp75) protects mitochondria and suppresses inflammation. This finding offers a new strategy for treating inflammation-associated diseases by modulating cytokine production.
Area of Science:
- Mitochondrial biology
- Immunology
- Cellular metabolism
Background:
- Mitochondria are increasingly linked to the generation of proinflammatory cytokines.
- Glucose-regulated protein75 (Grp75/mortalin) is a mitochondrial chaperone that protects mitochondria.
- The role of Grp75 in modulating lipopolysaccharide (LPS)-induced inflammatory responses in microglial cells remains to be fully elucidated.
Purpose of the Study:
- To investigate the effect of Grp75 on the lipopolisaccharide (LPS)-induced inflammatory response in microglial BV-2 cells.
- To determine how Grp75 influences metabolic changes and mitochondrial function during LPS-induced activation.
- To explore the potential of Grp75 as a therapeutic target for inflammation-associated pathologies.
Main Methods:
- Utilized microglial BV-2 cell line.
- Induced inflammatory response using lipopolisaccharide (LPS).
- Overexpressed glucose-regulated protein75 (Grp75).
- Assessed metabolic changes, mitochondrial function, oxidative stress, and proinflammatory cytokine production.
- Investigated the involvement of NF-κB activation and lactate.
Main Results:
- LPS-induced activation caused significant metabolic alterations, including suppressed mitochondrial function and increased glycolysis.
- Overexpression of Grp75 attenuated LPS-induced oxidative and metabolic responses.
- Grp75 overexpression suppressed proinflammatory activation, which was dependent on both NF-κB activation and lactate production.
- LPS-induced inflammation in microglial cells involves metabolic shifts that can be modulated by Grp75.
Conclusions:
- Overexpression of Grp75 mitigates LPS-induced inflammatory responses in microglial cells.
- Grp75 plays a protective role by preserving mitochondrial function and reducing metabolic disturbances during inflammation.
- Targeting Grp75 represents a novel therapeutic strategy for managing inflammation-associated diseases through modulation of cytokine production.
